GE cuts some debt using proceeds from sale of biopharma business <!-- no image --> <div>General Electric Co said on Monday it used part of the $20 billion in proceeds from the sale of its biopharma business to cut debt.<div class="feedflare"> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=Ij4SHmgfF-M:PPCKjElZF2A:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?d=yIl2AUoC8zA" border="0"></a> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=Ij4SHmgfF-M:PPCKjElZF2A:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?i=Ij4SHmgfF-M:PPCKjElZF2A:V_sGLiPBpWU" border="0"></a> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=Ij4SHmgfF-M:PPCKjElZF2A:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?i=Ij4SHmgfF-M:PPCKjElZF2A:F7zBnMyn0Lo" border="0"></a> </div><img src="http://feeds.feedburner.com/~r/reuters/UKBankingFinancial/~4/Ij4SHmgfF-M" height="1" width="1" alt=""></div> Posted by Reuters